Uniformed Services University of the Health Sciences
Department of Preventive Medicine and Biometrics
4301 Jones Bridge Road
Bethesda, Maryland 20814-4799
COL Aizen Marrogi is a currently a faculty within division of Global Health, Department of Preventive Medicine and Biometric, USUHS in Bethesda, MD. He recently return from an overseas deployment as a command surgeon for the office of security Cooperation (OSC-I) with US mission in Baghdad, Iraq. Where he served as medical advisor to the chief of the office of Security Cooperation on all health matters regarding immunization, health force protection of US uniformed, DoD civilian and contractors. He initiated more than half a billion in medical Foreign Military Sales in support of US modernization effort of Iraqi Security Forces including the F-16 and Apache programs. He is also the US Army Surgeon General Liaison office the Iraqi Ministry of Defense. In this capacity, he coordinates with Iraqi MOD, CentCom, OTSG and MTFs for Training of the Iraqi Health care providers from MOD. He completed a commander appointment position as the Chair of the Institutional review Board (IRB) tasked with approving all human subject research through-out Walter Reed Army Research Institute (WRAIR) Worldwide operation. He is also staff pathologist at the new Walter Reed National Medical center in Bethesda, MD.
COL Marrogi is a designator "A" which is the highest academic title within the DoD Medical Department, and his awards include Meritorious Service Medal (twice), Army Achievement Medal, Army Commendation Medal, National Defense Ribbon (twice), Army Service Ribbon, Overseas Reserve Ribbon, Reserve Component Overseas Training Ribbon, Flight Surgeon Wing, Global War on Terrorism Medal.
Col Marrogi is proud of his Chaldean and Iraqi Heritage. He speaks, reads and writes in Syriac, Arabic and French languages.
Dr. Marrogi's research interests are in Cancer Biology and Carcinogenesis, in particular the role of oxidative stress and redox regulatory pathways, gene therapy, molecular biomarkers and epidemiology. In addition to his work on the in-silco drug discovery, he has been exploring the role of plants phenolics extracts on several disease models including, Malaria, and Cancer. He has authored more than 150 original and review papers, abstracts and book chapters. He is a reviewer for a dozen medical journals and has served on several Grant Review Study Sections for both the department of Defense and National Institutes of Health. He is the founder of the United State Military Cancer Institute Bio-specimen Network which represents a Department of Defense effort in supporting National Cancer Institute's drive to acquire human samples for medical research. He is developing a program in effect of UV exposure on skin and immunity in deployed US troops. He is also actively engaged in designed a study of prevalence of no- neoplastic lung diseases in Iraqi native population. He is a great advocate of using soft powers such as Medicine and Science as to promote US Strategic partnership with Arab and Muslim world. He recently wrote an article to be published in Joint Forces Quarterly in April, 2014 entitled "Medical Diplomacy in International Relations: Concepts and Roles in Achieving US Global Strategic Objectives".
Cancer biology and carcinogenesis; molecular biomarkers, epidemiology; Bio-repository; and Botanical Drug Discovery for Oncology and Military Medicine.
Peer-Reviewed publications: 70
Book reviews: 2
Clinical Protocols: 8
Oral or Poster Presentations: 4
Marrogi. A. J., Duilami, S.: Medical Diplomacy in International Relations: Concepts and Roles in Achieving US Global Strategic Objectives. Joint Forces Quarterly, April, 2014
Levin,L.I., Kitchen, C. M. R., Liao, E., Kim, B., K., Marrogi, A., J., Widney, D., Krampf , R., Magpantay, L, Breen, E., Martínez-Maza, O. Elevated serum levels of CXCL13 precede the diagnosis of B cell non-Hodgkin lymphoma, Submitted to JNCI.
Schwarzenberger, P., Byrne, Gaumer, R., Norton, J., Harrison, J, Marrogi, A. J., Kolls , J. Intra-Tumoral Drug Assessment of Mesothelioma Patients Following Treatment with PA1STK Cells and Ganciclovir. Can Gen Therapy 2011, 18:906-12.
Enewold L, Zhou J, Devesa SS, Berrington de Gonzalez A, Anderson WF, Zham SH, Stojadinovic A, Peoples GE, Marrogi AJ, Potter JF, McGlynn KA, Zhu K. Thyroid cancer incidence among active duty U.S. military, 1990-2004. Cancer Epidemiol Biomarkers Prev. 2011, 20:2369-76